Abstract
Recent reports identify the ratio between absolute neutrophil count (ANC) and absolute lymphocyte count (ALC), called neutrophil to lymphocyte ratio (NLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. We retrospectively examined the NLR in a cohort of 309 newly diagnosed multiple myeloma (MM) patients treated upfront with novel agents. NLR was calculated using data obtained from the complete blood count (CBC) at diagnosis and subsequently correlated with PFS and OS. The median NLR was 1.9 (range 0.4–15.9). Higher NLR was independent of international staging system (ISS) stage, plasma cell infiltration or cytogenetics. The 5-year PFS and OS estimates were, respectively, 18.2 and 36.4 % for patients with NLR ≥ 2 versus 25.5 and 66.6 % in patients with NLR <2. Among younger patients (age
Original language | English |
---|---|
Pages (from-to) | 1875-1883 |
Number of pages | 9 |
Journal | Annals of Hematology |
Volume | 94 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 22 2015 |
Keywords
- Granulocyte
- ISS
- Lymphocyte
- Multiple myeloma
ASJC Scopus subject areas
- Hematology
- Medicine(all)